DARWIN EU® - Cancer incidence during pregnancy

14/07/2026
14/07/2026
EU PAS number:
EUPAS1000001059
Study
Ongoing
Subscribe
Download as PDF
Study summary
No information provided.
Study identification

EU PAS number

EUPAS1000001059

Study ID

1000001059

Official title and acronym

DARWIN EU® - Cancer incidence during pregnancy

DARWIN EU® study

Yes

Study countries

Norway
Spain
United Kingdom

Study description

Few studies have examined the incidence of cancer during pregnancy, and existing evidence from studies conducted in Europe is limited. Real-World Evidence (RWE) regarding the precise incidence of cancer during pregnancy can help address this gap by providing more recent estimates from different European countries, informing future research priorities, and contributing to evidence-based decision-making in this vulnerable population.

Study status

Ongoing
Research institutions and networks

Institutions

Networks

Contact details

Berta Raventos

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable